Related Experiment Video

Updated: May 24, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

The role and impact of research agendas on the comparative-effectiveness research among antihyperlipidemics

A G Dunn1, F T Bourgeois, S Murthy

  • 1Centre for Health Informatics, Australian Institute of Health Innovation, University of New South Wales, Sydney, New South Wales, Australia. a.dunn@unsw.edu.au

Clinical Pharmacology and Therapeutics
|March 2, 2012
PubMed

Insights

Funding source significantly impacts clinical trial design. Industry-funded trials focus on drug comparisons and dyslipidemia, with fewer safety outcomes, revealing distinct research agendas.

Area of Science:

  • Clinical Trials
  • Health Services Research
  • Pharmacoeconomics

Background:

  • Funding source is known to affect clinical trial publication rates.
  • Limited understanding exists regarding how funding influences clinical trial design.
  • Antihyperlipidemic drug trials provide a relevant case study for examining funding impacts.

Purpose of the Study:

  • To investigate the influence of funding source on the design of clinical trials for antihyperlipidemic drugs.
  • To quantify differences in research agendas based on trial funding.
  • To identify potential areas for improving clinical trial alignment with patient needs.

Main Methods:

  • Analysis of 809 antihyperlipidemic clinical trials identified from a public registry of 72,564 trials.
  • Automated process used for trial identification and data extraction.
  • Construction of three distinct networks representing industry-, collaboratively, and non-industry-funded trials, with drugs as nodes and comparisons as connections.

Main Results:

  • Industry-funded trials demonstrated a higher likelihood of comparing different drugs within the antihyperlipidemic class.
  • Industry-funded trials were more focused on examining dyslipidemia as a condition.
  • A lower proportion of industry-funded trials registered safety outcomes compared to other funding sources.

Conclusions:

  • The source of funding measurably affects clinical trial design, highlighting variations in research priorities.
  • Understanding these funding-driven differences is crucial for interpreting trial results and assessing research agendas.
  • Enhanced monitoring of clinical trials could help ensure research aligns more closely with critical clinical needs.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...